Search results for: 'part cold consumer behavior saudi'

Women’s health is moving beyond single-condition apps and episodic visits toward connected care that follows each life stage—from adolescence to pregnancy and postpartum, through perimenopause and healthy aging. What makes this feasible now is the convergence of policy tailwinds (e.g., expanded postpartum coverage), AI+ at-home diagnostics (earlie...

Globally, diagnosis of metabolic diseases such as type 2 diabetes and obesity have increased. Since the COVID-19 pandemic, the global prevalence of obesity has worsened. Obesity is considered a main precursor of diabetes and contributes an estimated 80% to 85% toward the risk of type 2 diabetes. As a result, the financial burden associated with hea...

The global pharmaceutical market is projected to reach approximately $1.72 trillion in 2026, with large molecules driving most incremental growth while small molecules remain the sector’s cash flow base. The current growth cycle concentrates on cardiometabolic and oncology, led by GLP-1 platforms and antibody–drug conjugates (ADCs). Competitive adv...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across structural heart therapies, diabetes and metabolic monitoring, interventional tools, surgical navigation, neuromodulation, surgical robotics, advanced wearables, and AI driven risk prediction and behavioral modelling.The issue f...

Cardiometabolic diseases, including cardiovascular disease (which encompasses coronary artery diseases, chronic/congestive heart failure, stroke, and hypertension), type 2 diabetes, and obesity, have been increasing globally. As a result, the healthcare cost burden has become significant and is anticipated to rise further. Existing drug therapies f...

Patients with neurological and psychiatric disorders often experience a low quality of life due to delays in diagnosis with traditional self-reporting and minimally invasive approaches. Despite medical innovations, the growing burden of neurological conditions remains a significant unmet need, calling for technologies that enable early diagnosis an...

The medical device industry faces significant pricing pressures as the consumables and services segment gains traction from activities tied to installing new equipment and replacing or refurbishing capital equipment. Medical device vendors are focused on new business models to provide multi-vendor services, online parts ordering, remote servicing, ...

09 Jul 2020  |  North America  |  Market Research

Post-pandemic Global Healthcare Market Outlook, 2020

Stakeholders to Focus on Resource Optimization, New Growth Segments, and Cost Rationalization in a New Era of ‘Healthcare Preparedness’

Infographics

×

Every year, the team of futurists, analysts, and consultants in Frost & Sullivan's Transformational Healthcare Group comes together to render a comprehensive analysis to predict the themes, technologies, and global forces that will define the next 12 to 18 months (future) for the healthcare industry. In light of the lessons learned from the COVID-1...

This research service provides an understanding of the significance and impact of digital therapeutics on the emerging applications. Digital therapeutics is evidence-based therapeutic intervention for prevention, management, and treatment of a specific disease condition; it has the potential to address needs that traditional treatments and therapie...